Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EJFQ | ISIN: FR001400IE67 | Ticker-Symbol: 6GD0
Frankfurt
13.02.26 | 15:25
0,230 Euro
-3,77 % -0,009
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
MYHOTELMATCH Chart 1 Jahr
5-Tage-Chart
MYHOTELMATCH 5-Tage-Chart
RealtimeGeldBriefZeit
0,2220,26314.02.
Dow Jones News
292 Leser
Artikel bewerten:
(1)

MyHotelMatch: Notice of an Ordinary and Extraordinary General Meeting on Monday February 2nd 2026

DJ MyHotelMatch: Notice of an Ordinary and Extraordinary General Meeting on Monday February 2nd 2026

MyHotelMatch 
MyHotelMatch: Notice of an Ordinary and Extraordinary General Meeting on Monday February 2nd 2026 
16-Jan-2026 / 08:31 CET/CEST 
Dissemination of a French Regulatory News, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
 
=---------------------------------------------------------------------------------------------------------------------- 
Notice of an Ordinary and Extraordinary General Meeting on Monday February 2nd 2026 

Paris, France - January 16th, at 8:30 AM - MyHotelMatch ("MHM") is pleased to announce the convening of an ordinary and 
extraordinary general meeting on Monday, February 2, 2026, at 10:00 a.m., at the offices of the law firm Lexelians, 
located at 11, avenue de l'Opéra - 75001 Paris. 
 
The notice of meeting for this general assembly was published in the Bulletin des Annonces Légales Obligatoires on 
Monday, December 29, 2025. The notice of convocation was published in the Bulletin des Annonces Légales Obligatoires on 
Friday, January 16, 2026. 
 
Shareholders will be asked to vote on the following agenda: 
 
Ordinary business: 
 
 -- Ratification of the appointment of Mr. Rudie Reedijk as a member of the Board of Directors; (First resolution) 
 -- Ratification of the appointment of Mr. Jelle Ypma as a member of the Board of Directors; (Second resolution) 
 -- Ratification of the appointment of Mr. David Cloetingh as a member of the Board of Directors; (Third resolution) 
 -- Appointment of Mr. Diede van den Ouden as a member of the Board of Directors; (Fourth resolution) 
 -- Approval of the transfer of the listing of the Company's financial instruments from Euronext Paris to Euronext 
  Growth Paris in accordance with Article L. 421-14, V of the French Monetary and Financial Code, and delegation of 
  powers to the Board of Directors to carry out said transfer; (Fifth resolution) 
 -- Authorization to the Board of Directors to allow the Company to buy back its own shares under Articles L. 22-10-62 
  and L. 225-210 et seq. of the French Commercial Code; (Sixth resolution) 
 -- Authorities; (Seventh resolution) 
Extraordinary business: 
 
 -- Change of corporate name; corresponding amendment to the bylaws; (Eighth resolution) 
 -- Change of corporate purpose; corresponding amendment to the bylaws; (Ninth resolution) 
 -- Change of registered office; corresponding amendment to the bylaws; (Tenth resolution) 
 -- Delegation of authority to the Board of Directors to decide on a reduction of share capital motivated by losses, 
  through a reduction of the nominal value of shares; (Eleventh resolution) 
 -- Delegation of authority to the Board of Directors to decide on a reduction of share capital not motivated by 
  losses, through a reduction of the nominal value of shares; (Twelfth resolution) 
 -- Authorization to the Board of Directors to reduce the share capital by canceling shares under Articles L. 22-10-62 
  and L. 225-210 et seq. of the French Commercial Code; (Thirteenth resolution) 
 -- Delegation of authority to the Board of Directors to increase the share capital by issuing, with preferential 
  subscription rights maintained, ordinary shares and/or securities granting access to the share capital and/or 
  securities granting entitlement to the allocation of receivables; (Fourteenth resolution) 
 -- Delegation of authority to the Board of Directors to increase the share capital by issuing, with preferential 
  subscription rights waived, ordinary shares and/or securities granting access to the share capital and/or 
  securities granting entitlement to the allocation of receivables; (Fifteenth resolution) 
 -- Delegation of authority to the Board of Directors to increase the Company's share capital with preferential 
  subscription rights waived for the benefit of a private placement, up to a limit of 30% of the share capital; 
  (Sixteenth resolution) 
 -- Delegation of authority to the Board of Directors to increase the share capital for the benefit of specifically 
  designated categories of persons; (Seventeenth resolution) 
 -- Authorization to increase the size of issuances in the event of excess demand; (Eighteenth resolution) 
 -- Authorization to the Board of Directors to increase the share capital, up to 10% of the share capital, as 
  compensation for contributions in kind consisting of equity securities or securities granting access to the share 
  capital; (Nineteenth resolution) 
 -- Delegation of authority to the Board of Directors to grant free shares, whether newly issued or existing, to 
  employees and corporate officers, up to 10% of the share capital; (Twentieth resolution) 
 -- Delegation of authority to the Board of Directors to increase the share capital for the benefit of employees and 
  corporate officers of the Company or related companies, with preferential subscription rights waived for the 
  benefit of employee savings plan participants; (Twenty-first resolution) 
 -- Setting of the aggregate ceiling for authorizations to issue shares, securities granting access to the share 
  capital, and securities representing receivables; (Twenty-second resolution) 
 -- Delegation of authority to the Board of Directors to issue share subscription warrants for the benefit of a 
  designated category of investors; (Twenty-third resolution) 
 -- Alignment of the rules governing the organization and deliberations of the Supervisory Board with applicable law; 
  corresponding amendment to the bylaws; (Twenty-fourth resolution) 
 -- Alignment of the rules governing the holding of general meetings with applicable law; corresponding amendment to 
  the bylaws; (Twenty-fifth resolution) 
 -- Authorities; (Twenty-sixth resolution) 
All documentation relating to this general meeting is available on the Company's website. 
 
### 

About MYHOTELMATCH 
MYHOTELMATCH is listed on Euronext Paris - Compartment C 
ISIN: FR001400IE67 - MHM - Bloomberg: MHM:FP 
MYHOTELMATCH is eligible for the PEA-PME. 
 
For more information, please visit myhotelmatch.com (Investor Relations section). 
 
MYHOTELMATCH Contacts 
contact@MHM-corporate.com 
 
Warning 
 
Regarding the merits of any transaction or the making of any investment decision. It does not constitute or include any 
confirmation or commitment by MHM (or any other person) regarding the present or future value of MHM ' business, its 
securities, its subsidiaries or any other assets of MHM . 
 
This press release contains forward-looking statements based on current beliefs and expectations regarding future 
events. These forward-looking statements may include projections and estimates and their underlying assumptions, 
statements regarding plans, objectives, intentions and/or expectations regarding future financial results, events, 
operations and services. and product development, as well as statements regarding performance or events. These 
statements are generally identified by the terms "expect", "anticipate", "believe", "intend", "estimate", "plan", 
"project", "may", "should" or the negative form of these and other similar expressions. These statements are not 
guarantees of future performance and are subject to inherent risks, uncertainties and assumptions regarding MHM and its 
subsidiaries and investments, trends in their businesses, future capital expenditures and acquisitions, developments 
relating to contingent liabilities, changes in global economic conditions or MHM ' principal markets, competitive 
market conditions and regulatory factors. The realization of these events is uncertain; their outcome could turn out to 
be different from that envisaged today, which is likely to significantly affect the expected results. Actual results 
may differ materially from those anticipated or implied in these forward-looking statements. Any forward-looking 
statements contained in this press release are made as of the date of this press release. Except as required by 
applicable law, MHM undertakes no obligation to revise or update any forward-looking statements, taking into account 
new information or future events. 

=---------------------------------------------------------------------------------------------------------------------- 
Regulatory filing PDF file 
File: MHM_Notice of an Ordinary and Extraordinary General Meeting 02022026 
=---------------------------------------------------------------------------------------------------------------------- 
Language:   English 
Company:   MyHotelMatch 
       58 avenue d'Iéna 
       75116 Paris 
       France 
E-mail:    contact@myhotelmatch.co 
Internet:   www.myhotelmatch.com 
ISIN:     FR001400IE67 
Euronext   MHM 
Ticker: 
AMF Category: Additional regulated information to be pubicly disclosed under the legislation of a Member State / Terms 
       of availability of the preparatory documents for the GM 
EQS News ID: 2261006 
  
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------ 

2261006 16-Jan-2026 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2261006&application_name=news&site_id=dow_jones%7e%7e%7ebed8b539-0373-42bd-8d0e-f3efeec9bbed

(END) Dow Jones Newswires

January 16, 2026 02:31 ET (07:31 GMT)

© 2026 Dow Jones News
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.